Bliss GVS Pharma Ltd

  • BSE Code : 506197
  • NSE Symbol : BLISSGVS
  • ISIN : INE416D01022
  • Industry :PHARMACEUTICALS - INDIAN - FORMULATIONS

up-arrow 180.20 6.47(3.72%)

Open Price ()

174.99

Prev. Close ()

173.73

Volume (No’s)

913,088

Market Cap ()

1,832.81

Low Price ()

174.00

High Price ()

183.19

 

Book Closure

From Date To Date Announcement
31-Jul-2025 NA 40th Annual General Meeting ('40th AGM or AGM') of the Company for the financial year ended March 31, 2025 has been scheduled to be held on Thursday, July 31, 2025 at 11:30 A.M. According to Section 91 of the Companies Act, 2013 and Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we hereby inform you that the Register of Members and Share Transfer Books of the Company will remain closed from Friday, July 25, 2025 to Thursday, July 31, 2025 (both days inclusive) for 40th AGM. Please find enclosed herewith the Intimation for Book Closure for the purpose of the 40th Annual General Meeting of the Company. (As Per BSE Announcement dated on 08.07.2025) Please find attached herewith the proceedings of 40th Annual General Meeting of Bliss GVS Pharma Limited. (As Per BSE Announcement Dated on: 31/07/2025)
29-Jul-2025 NA Bliss GVS Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2025 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30 2025. Please find enclosed intimation in this regard We would like to inform you that, the Board Meeting of the Company was held today i.e. on Tuesday, July 29, 2025 at the registered office of the Company. In pursuant to Regulation 30 and Regulation 33 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board has considered and approved the the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2025. A copy of unaudited standalone and consolidated financial results along with the Limited Review Report of the Auditors. We wish to inform you that the Board of Directors at its meeting held today i.e. Tuesday, July 29, 2025 has considered and approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2025. (As Per BSE Announcement Dated on :29.07.2025)
25-Jul-2025 31-Jul-2025 According to Section 91 of the Companies Act, 2013 and Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we hereby inform you that the Register of Members and Share Transfer Books of the Company will remain closed from Friday, July 25, 2025 to Thursday, July 31, 2025 (both days inclusive) for 40th AGM. Please find enclosed herewith the Intimation for Book Closure for the purpose of the 40th Annual General Meeting of the Company. (As Per BSE Announcement dated on 08.07.2025)
24-Jul-2025 NA Rs.0.5000 per share(50%)Final Dividend
24-Jul-2025 NA 50% Final Dividend

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew